PRELUDE?
Faced with a past with little progress, great challenges are foreseen in the future, since dissatisfaction around unmet needs is added to the issue of sexual orientation, identity and gender, reinforcing the notability of the exclusion of this portion of citizens, who have left out of clinical research and the development of specific policies11. In addition, the significant impacts of the COVID-19 pandemic are also beginning to be perceived in contraception and PRp, with a 9.1% drop in the number of women using contraception12,13.
Achieve progress in order to meet the reproductive intentions of women will only occur when investments in health are guided by the quality procedures and largely attend the population, covering age groups, social levels and varied profiles14. Given the challenges presented and aiming to minimize the financial impacts, the damming of demand experienced should be absorbed by the health system in the coming years, the IMP-ETN can be considered a contraceptive option of clinical and socioeconomic interest to public and private sector of health.
World Health Organization lists limited access to good quality services and choice of method; experience, or fear, of side effects; cultural or religious opposition, user and provider bias, and gender-based barriers as potential reasons for women not using available contraceptive methods. Changes in infrastructure and better training of providers to educate, especially about the predilection for LARCs, would be good initiatives to achieve lower rates of unplanned pregnancies and abortions.